NovaBridge Biosciences
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $590.6M
Liabilities Breakdown FY2022
Total Liabilities: $168.7M
Asset Breakdown
Total Assets: $590.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $342.9M | 58.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $8.8M | 1.5% |
| Goodwill | $23.6M | 4.0% |
| Intangible Assets | $17.2M | 2.9% |
| Other Assets | $198.1M | 33.5% |
Liabilities Breakdown
Total Liabilities: $168.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $102.4M | 60.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $66.3M | 39.3% |